Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search

		Submit


Ebola Disease


Section Navigation
			
			CDC Home








Guide for State, Tribal, Local, or Territorial Public Health Departments Monitoring a Returned Traveler for Ebola Disease						Print
																Related Pages
										Print this guide [PDF – 1 page] for help with monitoring a returned traveler for Ebola disease.
After entry into the United States
Travelers from an outbreak country or from a designated outbreak area (with no known exposure) will experience minimum public health monitoring expectations and guidance from CDC based on available resources.
Travelers who have reported a high-risk exposure should quarantine and be monitored daily for 21 days.
Any monitored traveler reporting fever (100.4°F/38.0°C) without use of antipyretics and any of the following symptoms should be directed to self-isolate until public health assessment determines next steps.
Aches and pains, such as severe headache and muscle and/or joint pain
Weakness and fatigue
Sore throat
Loss of appetite
Gastrointestinal symptoms, including abdominal pain, diarrhea, and vomiting
Unexplained hemorrhaging, bleeding or bruising, including bleeding outside a normal menstrual cycle
Red eyes, skin rash, and hiccupsConsultation with clinical team for testing recommendations of patients with an exposure risk and symptoms compatible with Ebola disease
An in-depth public health interview will be conducted with the clinical team to review a detailed travel and epidemiologic history and clinical course of the patient. Questions related to risk exposure, like these below, can help inform testing recommendations.
Did the patient:
Have contact with a symptomatic person with suspected or confirmed Ebola disease, or any objects contaminated by their body fluids?
Experience a breach in Infection Prevention and Control (IPC) precautions that result in the potential for contact with body fluids of a patient with suspected or confirmed Ebola disease?
Have contact with semen from a man who has recovered from Ebola disease?
Participate in any of the following activities while in an area with an active Ebola disease outbreak?
Contact with someone who was sick or died, or any objects contaminated by their body fluids
Attend/participate in funeral rituals, including preparation of bodies for funeral/burial
Work in a healthcare facility or laboratory
Visit a healthcare facility or traditional healer
Contact with bats or wild animals
Work or spend time in a mine/caveAs a resource for State, Tribal, Local, or Territorial public health departments, CDC is available 24/7 for consultation 770-488-7100.
Testing algorithm
Through the consultation process, if the decision is made to test for ebolavirus, testing for other causes of illness should continue (refer to Performing routine diagnostic testing for patients with suspected Ebola disease for guidance). In addition, a determination should be made on whether the patient requires transfer to a higher tier facility. If the decision is made NOT to test for ebolavirus, a follow up clinical consultation is recommended to review the patient’s clinical status and laboratory test results and to discuss discontinuation of Ebola specific IPC measures.
When the decision has been made to test the patient, the following testing algorithm can be used:
**If a sample is collected less than 72 hours after symptom onset** and tests positive, the patient is considered a confirmed Ebola case*. If the sample tests negative and the patient is still symptomatic, the test should be repeated 72 hours after symptom onset as the test may produce a false negative if the specimen is collected less than 72 hours after symptom onset. The patient must remain under strict isolation precautions during this time.
**If the test is repeated 72 hours after symptom onset** and the test is positive, the patient is considered a confirmed Ebola case*. If the test is negative, a follow up clinical consultation is recommended to review the patient’s clinical status and laboratory test results and to discuss discontinuation of Ebola specific IPC measures.
**If the initial sample is collected over 72 hours after symptom onset** and the test is positive, the patient is considered a confirmed Ebola case*. If the test is negative, a follow up clinical consultation is recommended to review the patient’s clinical status and laboratory test results and to discuss discontinuation of Ebola specific IPC measures.
* Positive and negative ebolavirus results received on a Biofire Warrior panel are considered presumptive. All ebolavirus laboratory test results must be confirmed by CDC.Reporting Confirmed Cases of Ebola Disease to CDCLearn more on case reporting recommendations at Domestic Ebola Disease Case Reporting Recommendations for Health Departments.
							
					
							Last Reviewed:  February 9, 2023						Source: 	Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP), Viral Special Pathogens Branch (VSPB)
					Facebook
        Twitter
        LinkedIn
        Syndicate homeEbola Disease
What is Ebola Disease?
Transmission
Signs and Symptoms
Prevention and Vaccineplus icon
Handwashing
Diagnosis
Treatmentplus icon
Survivors
Outbreaksplus icon
History of Ebola Outbreaks
Ebola Disease Distribution Map: Cases of Ebola Disease in Africa Since 1976
September 2022 Uganda, Mubende District
August 2022 Democratic Republic of the Congo, North Kivu
April 2022 Democratic Republic of the Congo, Equateur Province
October 2021 Democratic Republic of the Congo, North Kivu Province
2021 Guinea, N’Zérékoré Prefecture
February 2021 Democratic Republic of the Congo, North Kivu Province
2020 Democratic Republic of the Congo, Equateur Province
2018 Eastern Democratic Republic of the Congoplus icon
Overview
What’s New
What CDC is Doing
Eastern Democratic Republic of the Congo Ebola Outbreak Map
Ebola Communication and Awareness Resources
2018 Democratic Republic of the Congo, Bikoro
2017 Democratic Republic of the Congo, Bas Uélé District
2014–2016 Ebola Outbreak in West Africaplus icon
The Cost of the Ebola Epidemic
2014–2016 Ebola Outbreak Distribution in West Africa
Case Counts
2014 Ebola Outbreak in West Africa Epidemic Curves
2014 Ebola Outbreak in Democratic Republic of the Congo
Outbreak Preparedness
Outbreak Response Storiesplus icon
A Focus on Ebola Response
It’s not over until it’s over
Long flights, long days mark vaccine campaign
Roads to Uganda
How community feedback shapes the Ebola response
Ebola outbreak becomes a class act for EIS officers
In the shadow of the volcano
Congo-born CDC photographer rooting for Ebola responders
Fighting Ebola on familiar ground
There’s no silver bullet
Strength In Numbers
Responding to a case of Ebola in Goma
Fighting Ebola: Every day is a Monday
Protecting the Health of Communities
Collaborating across Time Zones
Being Creative in Goma
Crunching the Numbers
Supporting the Laboratory in Uganda
Supporting the Ministry of Health
Protecting Uganda’s Border
Watching DRC’s Border
Cliniciansplus icon
Ebola Disease for U.S. Cliniciansplus icon
Infection Prevention and Control
Acute Hemodialysis
Pregnant Women
Handling Human Remains
Neonatal Care
Ebola Vaccine: Information about ERVEBO®plus icon
Contraindications and precautions for ERVEBO®
Administration of ERVEBO®
Request initial doses ERVEBO®
Request Booster Doses of ERVEBO®
Screening Patientsplus icon
Guide for Evaluating an Ill Person
Management of Survivors
Considerations for Discharging people under evaluation for selected Viral Hemorrhagic Fevers (VHF)
Hospital Guidance
Survivability of Ebolaviruses in Medical Waste
Handling Ebola-Associated Waste
Emergency Servicesplus icon
EMS Systems and 9-1-1 Answering Points
Air Medical Transport SOP
Patient Handoff SOP
Air-to-Ground Patient Handoff SOP
Ambulance Decontamination
Personal Protective Equipment (PPE)plus icon
Guidance for Confirmed Ebola Patients or Clinically Unstable PUIs
Guidance for Clinically Stable PUIs
Ebola PPE Frequently Asked Questions
Non-US Healthcare Settingsplus icon
Preventing Injury from Injections and Sharps in Non-U.S. General Healthcare Settings
Hand Hygiene in Non-U.S. General Healthcare Settings
Rationale and Considerations for Chlorine Use in Infection Control for Non- U.S. General Healthcare Settings
Laboratory Testingplus icon
Specimen Collection, Transport, and Submission
Packing and Shipping Specimens
Managing and Testing Routine Clinical Specimens
Non-CDC Resources
Health Departments and Plannersplus icon
Guide for Monitoring a Returned Traveler
Case Reporting Recommendations
Top 10 Ebola Response Planning Tips
Hospital Preparednessplus icon
Preparing Frontline Healthcare Facilities
Preparing Ebola Assessment Hospitals
Preparing Ebola Treatment Centers
Cleaning and Decontaminationplus icon
Guidance for Decontamination and Removal of Ebolavirus-Contaminated Waste for U.S. Residence
Guidance for Handling Untreated Sewage
FAQs: Guidance for Managers and Workers Handling Untreated Sewage from Patients with Suspected or Confirmed Ebola Disease in the U.S.
Guidance for Cleaning, Disinfection, and Waste Disposal in Commercial Passenger Aircraft
Resourcesplus icon
Communication Materialsplus icon
Videos and Audio
Posters and Factsheets
Media Archive
Training


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue